When Alexander Graham Bell demonstrated the telephone at America’s Centennial Exposition in Philadelphia in 1876, the invention amazed the crowd. But what would truly set it apart wasn’t just the device; it was the ecosystem that enabled the invention to spread, be useful in society, and generate commercial returns. Bell and his associates formed the Bell Telephone Company (1877), adopted a leasing model, secured patents, settled a pivotal dispute with Western Union (1879), and participated in building the manufacturing and long-distance infrastructure that scaled the telephone nationwide in the next decade. That fusion of technical progress and institutional design would become a defining American pattern.

For 250 years, the U.S. has specialized not just in inventing new technologies but also in (re)inventing ways of bringing them to market. From early patent law to research universities, corporate labs, wartime partnerships, and venture capital, every generation has reshaped the machinery that connects science to the marketplace. America’s true comparative advantage has been its institutional ingenuity, the capacity to build new ways of turning ideas into industries. For the next 250, that institutional reflex — not any single technology — is what must be consciously preserved and extended.

From Jefferson’s Patent Desk to the Corporate Lab

The republic’s first major institutional innovation was the way it designed its patent system, a radical democratization of invention relative to European systems. Thomas Jefferson’s design invited useful inventions from ordinary citizens (not just aristocrats or state-sponsored academies) to be examined based on merit. Low filing fees, clear ownership rights, and public disclosure represented a departure from prior systems, enabling a market for inventions. By the mid-19th century, Americans were patenting innovations at a rate several times that of Britain’s per capita rate. Not only were inventions more numerous, but consequential inventions also emerged during this period, including the McCormick mechanical reaper, the Colt revolver, and Goodyear’s vulcanization process. Many of these inventions quickly spawned new firms, accelerating America’s entrepreneurial dynamism.

Yet even as the U.S. patent system democratized invention, the nation soon faced a new challenge: how to industrialize and systematically improve these discoveries. That challenge gave rise to the next wave of American institutional innovation, the corporate research laboratory. By the early 20th century, companies such as General Electric, DuPont, and Bell Labs institutionalized invention itself. These labs insulated scientists from quarterly pressures, paired them with engineers who could scale breakthroughs, and treated knowledge creation as a core corporate function. Within such labs emerged the transistor and information theory, which formed the intellectual foundation of the digital age. Their breakthroughs, and the talent they developed, supplied the raw materials for later waves of entrepreneurship.

Still, corporate R&D alone could not meet the technological demands of World War II, and the United States responded by inventing a new organizational form: the public–private research partnership. Vannevar Bush’s wartime Office of Scientific Research and Development linked federal funding, academic talent, and industrial production lines. The result was radar, penicillin, and the foundations for later advances in biological research and information technology. These temporary mobilizations left a lasting impact: Americans learned to align government risk capital with private-sector execution.

But success in scientific discovery created its own bottleneck. By the 1940s, the country excelled at generating discoveries but lacked a system for financing  the commercial leap — particularly for ventures too risky for banks and too early-stage for corporate R&D.

The Venture Capital Revolution — and What It Means for 2125

In 1946, an émigré Frenchman turned Harvard professor, Georges Doriot, proposed an audacious remedy. He founded the American Research and Development Corporation (ARD) in Boston to fund promising technologies emerging from universities and wartime laboratories. ARD raised $3.5 million (then a remarkable sum) from insurance companies, university endowments, and wealthy individuals. Its goal was to commercialize early-stage technologies too risky for conventional finance.

ARD did so through a set of structural innovations. It provided equity capital rather than loans, aligning founders, scientists, and investors around long-term growth rather than quick repayment. It practiced staged financing, releasing money in tranches as entrepreneurs met technical milestones (a way to introduce discipline without suffocating risk-taking). ARD treated managerial oversight as part of the investment, reflecting Doriot’s conviction that the purpose was to build companies, not just finance them. The model’s triumph arrived with Digital Equipment Corporation, whose minicomputers revolutionized computing and delivered a 500-fold return for ARD investors after its 1966 IPO.

Yet ARD was itself an experiment constrained by regulation. Organized as a publicly traded investment company, it was subject to the 1940 Investment Company Act, which restricted its ability to share profits, use leverage, and structure incentives. Investors inspired by ARD’s model soon created private limited partnerships, which avoided these constraints, entities such as Greylock and Venrock in the 1960s, followed by Kleiner Perkins and Sequoia Capital in the 1970s. Unburdened by public company rules, these partnerships could design strong incentives and reinvest their gains into subsequent new funds. By the 1970s, this evolution had crystallized into the modern venture-capital firm.

This evolution highlighted a defining feature of the American system: when existing institutions limit progress, entrepreneurs invent new ones. Venture partnerships emerged as such an institutional innovation. They combined scientific insight, entrepreneurial initiative, and financial-market discipline into a novel mechanism for financing high-risk ideas. By embracing power-law outcomes (expecting a few extraordinary successes to offset many failures), they helped normalize a culture in which entrepreneurial misfires became a valuable experience, not a disqualification.

The venture model addressed a fundamental coordination problem: how to fund projects whose technical and commercial prospects are deeply uncertain. Staged funding and equity incentives gave investors and founders room to learn and adjust. By the late 20th century, this architecture powered industries from semiconductors to biotechnology. And the legal infrastructure around it— limited-partnership law, favorable capital-gains treatment, and university technology transfer under the 1980 Bayh-Dole Act, completed a uniquely American pathway from scientific discovery to enterprise.

No other country replicated the U.S. venture model. Europe continues to produce world-class science, yet its fragmented capital markets, stricter labor and bankruptcy regimes, and smaller, more risk-averse funds have made it harder to match the American combination of flexible capital and entrepreneurial rewards. China has mobilized enormous resources through state-guided venture funds, but these vehicles often prioritize strategic industrial objectives over open-ended experimentation. The distinctive strength of the U.S. system is its decentralized structure: hundreds of independent investors placing parallel bets under clear legal rules but minimal coordination, producing a level of experimentation — and serendipity — that is difficult for more centralized systems to match.

The AI Era Is the Latest Proof

[Rationale: “Echoes” is passive and academic. “The AI Era Is the Latest Proof” is declarative, forward-scanning, and matches Fortune’s commentary header style.]

That same pattern is visible today in artificial intelligence, the defining technology of the moment. The U.S. and China produce comparable volumes of AI research, but their commercialization ecosystems diverge sharply. In the U.S., thousands of startups (funded by private venture capital and staffed by global talent) are pursuing thousands of AI applications, from drug discovery to logistics to creative media. China, by contrast, channels efforts through a handful of national champions and state-aligned labs, prioritizing rapid deployment over decentralized experimentation.

[Unchanged.]

As in earlier eras, the contrast is centralized direction versus distributed discovery. America’s advantage has rarely been coordination; it has been adaptive disorder. Experiments fail often, but the system learns quickly because entry is cheap, exit is tolerated, and capital recycles rapidly. That logic runs from Doriot’s Boston office in 1946 back to the nation’s long habit of institutional reinvention.

My Vision for the Next 100 Years

The story of American innovation isn’t a straight line from telegraph to transistor to AI. It is a story of institutional succession,with each generation building new mechanisms to link discovery with enterprise. The 19th-century patent system rewarded tinkerers; corporate labs scaled systematic research; wartime partnerships mobilized national resources; and venture capital democratized risk-taking. Today, as AI, clean energy, and biomanufacturing demand immense computing power and patient capital, new hybrids are emerging: public research consortia backed by private investment, and regional hubs pairing universities with manufacturing accelerators.

The challenge for today’s leaders is to preserve the features that made earlier models work: openness to global talent, flexible capital markets, and a social contract that views failure as information, not disgrace. America’s most important innovation has never been a single technology but the capacity to reinvent the institutions of innovation themselves. As the nation approaches its 250th birthday, that institutional reflex remains its deepest strength. Bell’s telephone, ARD’s early venture bets, and today’s AI startups all reflect the same enduring pattern: a country that redesigns how ideas become reality — powered by entrepreneurship as much as by science.

That institutional reflex, cultivated over 250 years, is the foundation on which the next century must be built.

The opinions expressed in Fortune.com commentary pieces are solely the views of their authors and do not necessarily reflect the opinions and beliefs of Fortune.